#VisualAbstract: Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer
Click here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No works may be ...
Tag: prostate cancer metastasis
Talazoparib plus enzalutamide improves progression-free survival in metastatic prostate cancer
1. Progression-free survival was significantly higher in the talazoparib plus enzalutamide group compared to enzalutamide alone. 2. There were no ...
#VisualAbstract: Abiraterone acetate improves survival in high-risk non-metastatic prostate cancer compared to control
1. Abiraterone acetate plus standard treatment significantly increased length of metastasis-free survival in men with non-metastatic prostate cancer compared to ...